UK Markets close in 1 hr 29 mins

Biotest Aktiengesellschaft (0N6Z.L)

LSE - LSE Delayed price. Currency in EUR
Add to watchlist
43.00+0.10 (+0.23%)
As of 07:03AM GMT. Market open.
Currency in EUR

Valuation measures4

Market cap (intra-day) N/A
Enterprise value N/A
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)N/A
Price/book (mrq)N/A
Enterprise value/revenue N/A
Enterprise value/EBITDA N/A

Trading information

Stock price history

Beta (5Y monthly) 0.43
52-week change 3N/A
S&P500 52-week change 3N/A
52-week high 30.00
52-week low 30.00
50-day moving average 3N/A
200-day moving average 3N/A

Share statistics

Avg vol (3-month) 3N/A
Avg vol (10-day) 3N/A
Shares outstanding 539.57M
Implied shares outstanding 6N/A
Float 819.96M
% held by insiders 189.88%
% held by institutions 10.55%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.04
Trailing annual dividend yield 30.09%
5-year average dividend yield 4N/A
Payout ratio 4N/A
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2021
Most-recent quarter (mrq)30 Jun 2022

Profitability

Profit margin -12.74%
Operating margin (ttm)-10.08%

Management effectiveness

Return on assets (ttm)-2.86%
Return on equity (ttm)-16.67%

Income statement

Revenue (ttm)510.9M
Revenue per share (ttm)12.74
Quarterly revenue growth (yoy)-0.40%
Gross profit (ttm)80.7M
EBITDA -24.4M
Net income avi to common (ttm)-65.1M
Diluted EPS (ttm)-0.80
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)85M
Total cash per share (mrq)2.21
Total debt (mrq)539.8M
Total debt/equity (mrq)150.49
Current ratio (mrq)4.27
Book value per share (mrq)11.16

Cash flow statement

Operating cash flow (ttm)48.6M
Levered free cash flow (ttm)3.67M